Tempest Therapeutics, Inc. (TPST)

Price & Market Data

Price: $1.87

Daily Change: +$0.06 / 3.21%

Daily Range: $1.84 - $2.06

Market Cap: $27,541,014

Daily Volume: 58,803

Performance Metrics

1 Week: -7.50%

1 Month: 3.93%

3 Months: -23.82%

6 Months: -48.75%

1 Year: -70.26%

YTD: -35.99%

About Tempest Therapeutics, Inc. (TPST)

Discover the market presence of Tempest Therapeutics, Inc. (TPST). Price: 1.87, daily change: +$0.06 / 3.21%. Market cap: 27,541,014. Performance across all periods for a clear financial view.

Company Details

Employees: 4

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.

Selected stocks

YXT.COM GROUP HOLDING LIMITED - American Depository Shares (YXT)

Jiuzi Holdings, Inc. (JZXN)

Apimeds Pharmaceuticals US, Inc. (APUS)

PetMed Express, Inc. (PETS)

Eve Holding, Inc. (EVEX)